High infectivity and pathogenicity of influenza A virus via aerosol and droplet transmission

Epidemics

Volumn 2, Issue 4, 2010, Pages 215-222

  Teunis, Peter F M ^a,b   Brienen, Nicole ^a   Kretzschmar, Mirjam E E ^a,c  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Aerosol exposure; Dose response; Droplet exposure; Infection risk; Influenza A virus

Indexed keywords

AEROSOL; ARTICLE; INFLUENZA VIRUS A; MONTE CARLO METHOD; PRIORITY JOURNAL; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS TRANSMISSION; VIRUS VIRULENCE;

AEROSOLS; AIR MICROBIOLOGY; COMPUTER SIMULATION; COUGH; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; INHALATION EXPOSURE; MODELS, BIOLOGICAL; MONTE CARLO METHOD; RESPIRATION; RISK ASSESSMENT; SNEEZING;

EID: 78650511334     PISSN: 17554365     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.epidem.2010.10.001     Document Type: Article

References (50)

1. Alford R.H., Kasel J.A., Gerone P.J., Knight V. Human influenza resulting from aerosol inhalation. Proc. R. Soc. Exp. Biol. Med. 1966, 122(3):800-804.
2. Atkinson M.P., Wein L.M. Quantifying the routes of transmission for pandemic influenza. Bull. Math. Biol. 2008, 70(3):820-867.
3. Baccam P., Beauchemin C., Macken C.A., Hayden F.G., Perelson A.S. Kinetics of influenza A virus infection in humans. J. Virol. 2006, 80(15):7590-7599.
4. Blachere F.M., Lindsley W.G., Pearce T.A., Anderson S.E., Fisher M., Khakoo R., Meade B.J., Lander O., Davis S., Thewlis R.E., Celik I., Chen B.T., Beezhold D.H. Measurement of airborne influenza virus in a hospital emergency department. Clin. Infect. Dis. 2009, 48(4):438-440.
5. Brankston G., Gitterman L., Hirji Z., Lemieux C., Gardam M. Transmission of influenza A in human beings. Lancet Infect. Dis. 2007, 7(4):257-265.
6. Brienen N.C.J., Timen A., Wallinga J., van Steenbergen J.E., Teunis P.F.M. The effect of mask use on the spread of influenza during a pandemic. Risk Anal. 2010, 30(8):1210-1218.
7. Chen S.C., Chio C.P., Jou L.J., Liao C.M. Viral kinetics and exhaled droplet size affect indoor transmission dynamics of influenza infection. Indoor Air 2009, 19(5):401-413.
8. Choppin P.W., Tamm I. Studies of two kinds of virus particles which comprise influenza A2 virus strains: I. characterization of stable homogeneous substrains in reactions with specific antibody, mucoprotein inhibitors, and erythrocytes. J. Exp. Med. 1960, 112:895-920.
9. Clements M.L., O'Donnell S., Levine M.M., Chanock R.M., Murphy B.R. Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus. Infect. Immun. 1983, 40(3):1044-1051.
10. Clements M.L., Betts R.F., Maassab H.F., Murphy B.R. Dose response of influenza A/Washington/897/80 (H3N2) cold-adapted reassortant virus in adult volunteers. J. Infect. Dis. 1984, 149(5):814-815.
11. Clements M.L., Betts R.F., Murphy B.R. Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection. Lancet 1984, 1(8379):705-708.
12. Clements M.L., Snyder M.H., Buckler-White A.J., Tierney E.L., London W.T., Murphy B.R. Evaluation of avian-human reassortant influenza A/Washington/897/80×A/Pintail/119/79 virus in monkeys and adult volunteers. J. Clin. Microbiol. 1986, 24(1):47-51.
13. Donald H.B., Isaacs A. Counts of influenza virus particles. J. Gen. Microbiol. 1954, 10:457-464.
14. Duguid J.P. The size and the duration of air-carriage of respiratory droplets and droplet nuclei. J. Hyg. Camb. 1946, 44(6):471-479.
15. Fabian P., Mcdevitt J.J., Dehaan W.H., Fung R.O.P., Cowling B.J., Hung Chan K., Leung G.M., Milton D.K. Influenza virus in human exhaled breath: an observational study. PLoS ONE 2008, 3(7):e2691.
16. Haas C.N. Estimation of risk due to low doses of microorganisms: a comparison of alternative methodologies. Am. J. Epidemiol. 1983, 118(4):573-582.
17. Harper G.J. Airborne micro-organisms: survival tests with four viruses. J. Hyg. 1961, 59:479-486.
18. Hatch T.F. Distribution and deposition of inhaled particles in respiratory tract. Bacteriol. Rev. 1961, 25:237-240.
19. Hemmes J.H., Winkler K.C., Kool S.M. Virus survival as a seasonal factor in influenza and polimyelitis. Nature 1960, 188:430-431.
20. Henle W., Henle G., Stokes J., Maris E.P. Experimental exposure of human subjects to viruses of influenza. J. Immunol. 1946, 52:145-165.
21. Hirst G.K. In vivo titrations of influenza virus and of neutralizing antibodies in chick embryos. J. Immunol. 1942, 45:285-292.
22. Horsfall F.L. On the reproduction of influenza virus; quantitative studies with procedures which enumerate infective and hemagglutinating virus particles. J. Exp. Med. 1954, 100(2):135-161.
23. Horsfall F.L. Reproduction of influenza viruses; quantitative investigations with particle enumeration procedures on the dynamics of influenza A and B virus reproduction. J. Exp. Med. 1955, 102(4):441-473.
24. Jao R.L., Wheelock E.F., Jackson G.G. Interferon study in volunteers infected with Asian influenza. J. Clin. Investig. 1965, 44(6):1062. Abstract, 57th Annual Meeting of the American Society for Clinical Investigation, Atlantic City, N.J., May 3, 1965.
25. Li S., Eisenberg J.N.S., Spicknall I.H., Koopman J.S. Dynamics and control of infections transmitted from person to person through the environment. Am. J. Epidemiol. 2009, 170(2):257-265.
26. Loudon R.G., Roberts R.M. Droplet expulsion from the respiratory tract. Am. Rev. Respir. Dis. 1967, 95(3):435-442.
27. Murphy B.R., Chalhub E.G., Nusinoff S.R., Kasel J., Chanock R.M. Temperature-sensitive mutants of influenza virus. III. Further characterization of the ts-1[E] influenza A recombinant (H3N2) virus in man. J. Infect. Dis. 1973, 128(4):479-487.
28. Murphy B.R., Sly D.L., Hosier N.T., London W.T., Chanock R.M. Evaluation of three strains of influenza A virus in humans and in owl, cebus, and squirrel monkeys. Infect. Immun. 1980, 28(3):688-691.
29. Murphy B.R., Clements M.L., Madore H.P., Steinberg J., O'Donnell S., Betts R., Demico D., Reichman R.C., Dolin R., Maassab H.F. Dose response of cold-adapted, reassortan influenza A/California/10/78 virus (H1N1) in adult volunteers. J. Infect. Dis. 1984, 149(5):816.
30. Murphy B.R., Clements M.L., Tierney E.L., Black R.E., Steinberg J., Chanock R.M. Dose response of influenza A/Washington/897/80 (H3N2) avian-human reassortant virus in adult volunteers. J. Infect. Dis. 1985, 152(1):225-229.
31. Nicas M., Jones R.M. Relative contributions of four exposure pathways to influenza infection risk. Risk Anal. 2009, 29(9):1292-2303.
32. Nicas M., Sun G. An integrated model of infection risk in a health-care environment. Risk Anal. 2006, 26(4):1085-1096.
33. Nicas M., Nazaroff W.W., Hubbard A. Toward understanding the risk of secondary airborne infection: emission of respirable pathogens. J. Occup. Environ. Hyg. 2005, 2:143-154.
34. Riley R.L. Airborne infection. Am. J. Med. 1974, 57(3):466-475.
35. Riley R.L., O'Grady F. Airborne Infection: Transmission and Control 1961, The Macmillan Company, New York.
36. Ryan M.A., Christian R.S., Wohlrabe J. Handwashing and respiratory illness among young adults in military training. Am. J. Prev. Med. 2001, 21(2):79-83.
37. Sears S.D., Clements M.L., Betts R.F., Maassab H.F., Murphy B.R., Snyder M.H. Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults. J. Infect. Dis. 1988, 158(6):1209-1219.
38. Snyder M.H., Clements M.L., Betts R.F., Dolin R., Buckler-White A.J., Tierney E.L., Murphy B.R. Evaluation of live avian-human reassortant influenza A H3N2 and H1N1 virus vaccines in seronegative adult volunteers. J. Clin. Microbiol. 1986, 23(5):852-857.
39. Tang J.W., Liebner T.J., Craven B.A., Settles G.S. A schlieren optical study of the human cough with and without wearing masks for aerosol infection control. J. R. Soc. Interface 2009, 6(Supplement 6):S727-S736.
40. Tellier R. Review of aerosol transmission of influenza A virus. Emerg. Infect. Dis. 2006, 12(11):1657-1662.
41. Teunis P.F.M., Havelaar A.H. The beta Poisson model is not a single hit model. Risk Anal. 2000, 20(4):511-518.
42. Teunis P.F.M., Nagelkerke N.J.D., Haas C.N. Dose response models for infectious gastroenteritis. Risk Anal. 1999, 19(6):1251-1260.
43. Teunis P.F.M., Chappell C.L., Okhuysen P.C. Cryptosporidium dose response studies: variation between isolates. Risk Anal. 2002, 22(1):175-183.
44. Teunis P.F., Moe C.L., Liu P., Miller S.E., Lindesmith L., Baric R.S., Le Pendu J., Calderon R.L. Norwalk virus: how infectious is it?. J. Med. Virol. 2008, 80(8):1468-1476.
45. Teunis P.F.M., Ogden I.D., Strachan N.J.C. Hierarchical dose response of E. coli O157:H7 from human outbreaks incorporating heterogeneity in exposure. Epidemiol. Infect. 2008, 136(6):761-770.
46. Weber T.P., Stilianakis N.I. Inactivation of influenza A viruses in the environment and modes of transmission: a critical review. J. Infect. 2008, 57(5):361-373.
47. Wei Z., McEvoy M., Razinkov V., Polozova A., Li E., Casas-Finet J., Tous G.I., Balu P., Pan A.A., Mehta H., Schenerman M.A. Biophysical characterization of influenza virus subpopulations using field flow fractionation and multiangle light scattering: correlation of particle counts, size distribution and infectivity. J. Virol. Meth. 2007, 144(1-2):122-132.
48. Xie X., Li Y., Chwang A.T.Y., Ho P.L., Seto W.H. How far droplets can move in indoor environments-revisiting the Wells evaporation-falling curve. Indoor Air 2007, 17:211-225.
49. Xie X., Li Y., Sun H., Liu L. Exhaled droplets due to talking and coughing. J. R. Soc. Interface 2009, 6(Supplement 6):S703-S714.
50. Youngner J.S., Treanor J.J., Betts R.F., Whitaker-Dowling P. Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild-type influenza infection in humans. J. Clin. Microbiol. 1994, 32(3):750-754.